Search alternatives:
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
mg decrease » _ decrease (Expand Search), nn decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 1,041 - 1,060 results of 103,057 for search '(( 50 ((ng decrease) OR (mean decrease)) ) OR ( 5 ((mg decrease) OR (a decrease)) ))', query time: 1.34s Refine Results
  1. 1041
    <i>N</i>-acylethanolamine hydrolysis inhibitors decrease N1E-115 cell viability.

    <i>N</i>-acylethanolamine hydrolysis inhibitors decrease N1E-115 cell viability. by Laurie Hamtiaux (199349)

    Published 2011
    Save to List
    Saved in:
  2. 1042
    Changes related to kidney staining in UUO mouse model.

    Changes related to kidney staining in UUO mouse model. by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1043
    Changes associated with kidney fibrosis in TGF-

    Changes associated with kidney fibrosis in TGF- by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1044
    Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF-

    Validation of MN705 treatment effects in human proximal tubular epithelial cells during TGF- by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1045
    Effect of MN705 treatment on TGF-

    Effect of MN705 treatment on TGF- by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1046
    The screening process of MN705.

    The screening process of MN705. by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1047
    Changes associated with kidney fibrosis and effects of MN705 treatment on TGF-

    Changes associated with kidney fibrosis and effects of MN705 treatment on TGF- by Wencheng Jin (13136262)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1048
    Plasmid and genomic changes detected in de-evolution trials.

    Plasmid and genomic changes detected in de-evolution trials. by Irina V. Bakhlanova (2636080)

    Published 2016
    Save to List
    Saved in:
  9. 1049
    Immunoblotting for insulin sensitivity markers.

    Immunoblotting for insulin sensitivity markers. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 1050
    S3 Data -

    S3 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 1051
    S2 Data -

    S2 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 1052
    S1 Data -

    S1 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 1053
    S4 Data -

    S4 Data - by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 1054
    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR.

    Immunoblotting for TGF-beta, alpha-actinin, MMP-13, and mTOR. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 1055
    Immunoblotting for JAK, STAT, and SMAD.

    Immunoblotting for JAK, STAT, and SMAD. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 1056
    Fibrosis and TUNEL staining.

    Fibrosis and TUNEL staining. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 1057
    Fibrosis markers.

    Fibrosis markers. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 1058
    Immunoblotting FOXO1 and insulin receptors.

    Immunoblotting FOXO1 and insulin receptors. by Dwight D. Harris (14484648)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  19. 1059
    LuxR G37V has decreased DNA-binding activity.

    LuxR G37V has decreased DNA-binding activity. by Chelsea A. Simpson (9579303)

    Published 2024
    Save to List
    Saved in:
  20. 1060
    Subcutaneous injections of IL-2 decrease PD-1 expression in CD4+ and CD8+ T cells.

    Subcutaneous injections of IL-2 decrease PD-1 expression in CD4+ and CD8+ T cells. by Vedran Brezar (337452)

    Published 2017
    Save to List
    Saved in:

Search Tools: